文献
J-GLOBAL ID:201802269794230210
整理番号:18A1569660
肥満細胞活性化疾患における新規治療法としてのヒドロキシクロロキン【JST・京大機械翻訳】
Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases
著者 (12件):
Espinosa Eric
(Inserm, U1037, Centre de Recherche en Cancerologie de Toulouse (CRCT), Toulouse F-31037, France)
,
Espinosa Eric
(Universite de Toulouse, Universite Paul Sabatier, Toulouse F-31062, France)
,
Valitutti Salvatore
(Inserm, U1037, Centre de Recherche en Cancerologie de Toulouse (CRCT), Toulouse F-31037, France)
,
Valitutti Salvatore
(Universite de Toulouse, Universite Paul Sabatier, Toulouse F-31062, France)
,
Laroche Michel
(Department of Rheumatology, Toulouse University and CHU, Toulouse, France)
,
Laurent Camille
(Department of Pathology, Institut Universitaire du Cancer, Toulouse Oncopole, University of Toulouse III Paul Sabatier, Toulouse, France)
,
Apoil Pol Andre
(Immunology Laboratory, Toulouse University Hospital, Toulouse, France)
,
Hermine Olivier
(CEREMAST, Department of Hematology, Necker Hospital, Paris-APH, Paris, France)
,
Lavit Michel
(Pharmacokinetics and Toxicology Laboratory, Toulouse University and CHU, Toulouse, France)
,
Paul Carle
(Paul Sabatier University, Mastocytosis National Reference Center (CEREMAST), Department of Dermatology, Toulouse University and CHU, Toulouse, France)
,
Bulai Livideanu Cristina
(Inserm, U1037, Centre de Recherche en Cancerologie de Toulouse (CRCT), Toulouse F-31037, France)
,
Bulai Livideanu Cristina
(Paul Sabatier University, Mastocytosis National Reference Center (CEREMAST), Department of Dermatology, Toulouse University and CHU, Toulouse, France)
資料名:
Clinical Immunology
(Clinical Immunology)
巻:
194
ページ:
75-79
発行年:
2018年
JST資料番号:
A1154A
ISSN:
1521-6616
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)